Clearstead Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-235
Closed -$2.05K 2060
2024
Q2
$2.05K Buy
+235
New +$2.05K ﹤0.01% 1812